Journals / Klinik Psikofarmakoloji Bülteni / 2013 / Cilt: 23 - Sayı: 4

Psikiyatristlere psikofarmakolojik ajanlarla ilişkili açılan malpraktis davaları: Dosya serileri

Malpractice claims against psychiatrists related to psychopharmacologic agents: File series

Pages
320–325
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, psychiatrists should improve their awareness about malpractice subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Psychiatrists are considered to be the least frequently sued among other medical specialties.
📊
Key Findings & Data:Of the 28 medical specialties, psychiatry ranked 22nd in terms of number of malpractice claims.
💡
Conclusion & Impact:Therefore, psychiatrists should improve their awareness about malpractice subjects.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Psychiatrists are considered to be the least frequently sued among other medical specialties. Of the 28 medical specialties, psychiatry ranked 22nd in terms of number of malpractice claims. We aimed to investigate psychopharmacotherapeutic malpractice claims against psychiatrists in Turkey. Methods: Data from claim files were extracted between the years of 2003 and 2012 in which expert witness testimony of psychiatrist and forensic specialists in the Council of Forensic Medicine were requested by the court. Only, claim files about psychopharmacotherapeutic issues were included in the study. Results: There were eight malpractice claim files selected according to the inclusion criteria. There were 3 female and 5 male patients in the related claims; four of them had a diagnosis of depression while the remaining four had schizophrenia. Four wrong treatments, one neglect and wrong treatment, one severe adverse effect, one accountability for death, one persecutory complaint about the prescribed drugs were cited in the claims. Conclusion: Malpractice claims against psychiatrists have been rising and this issue might have some negative influences on interrelations between psychiatrists. Therefore, psychiatrists should improve their awareness about malpractice subjects.

Özet

Amaç: Psikiyatristlerin diğer uzmanlıklara göre enaz dava edildikleri düşünülmektedir. Yirmisekiz tıpuzmanlığı içinde psikiyatri açılan malpraktis dava sayısı açısından 22. sırada gelmektedir. Biz, Türkiye’depsikofarmakoloji ile ilişkili psikiyatristlere açılan malpraktis dava konularını araştırmayı amaçladık. Yöntem: Olgular Adli Tıp Kurumu’na psikiyatrik ve adli tıbbi bilirkişilik için mahkeme tarafından gönderilen 2003-2012 yılları arasındaki dosyalardan seçildi. Çalışmaya yalnızca psikofarmakolojik ajanlarla ilişkilidava dosyaları alındı. Bulgular: Çalışmaya dahil etme ölçütlerine göre sekiz malpraktis davası saptandı. Dava dosyalarının üçü kadın ve beşi erkek hastaya aitti ve dördünde depresyon vegeri kalan dördünde ise şizofreni tanıları vardı. Reçeteedilen ilaçlarla ilgili dördünde yanlış tedavi, birindeihmal ve yanlış tedavi, birinde ciddi ilaç yan etkisi,birinde ölümden sorumlu tutulma ve birinde kötülükgörme yakınması saptandı.Sonuç: Psikiyatristlere karşı malpraktis davalarıartmaktadır ve bu konunun psikiyatristler üzerine negatif etkileri olabilecektir. Bu nedenle, psikiyatristler malpraktis konuları hakkındaki farkındalıklarınıartırmalıdır.

🔖

Cite This Article

DEMİREL, O. F., OZVER, I., EMUL, M., SAHİN, E., SEVİNDİR, E., OZEN, S. (2022). Psikiyatristlere psikofarmakolojik ajanlarla ilişkili açılan malpraktis davaları: Dosya serileri. Klinik Psikofarmakoloji Bülteni, Cilt: 23 - Sayı: 4, 320–325. https://ajindex.com/articles/574091

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Localio A, Lawthers A, Brennan T. Relation between malpractice claims and adverse events due to negligence. N Engl J Med 1991;325(4):245-51
  2. Jena AB, Seabury S, Lakdawalla D, Chandra A. Malpractice Risk According to Physician Specialty. N Engl J Med 2011;365(7):629-36
  3. Tsao CI, Layde JB. A basic review of psychiatric medical malpractice law in the United States. Compr Psychiatry 2007;48(4):309-12
  4. Blinder M. Suicide, psychiatric malpractice, and the bell curve. J Am Acad Psychiatry Law 2004;32(3):319-23
  5. Slawson P. Psychiatric malpractice and ECT: a review of 1,700 claims. Convuls Ther 1991;7(4):255-61
  6. Simon R. Therapist-patient sex: from boundary violations to sexual misconduct. Psychiatr Clin North Am 1999;22:31-47
  7. Cannel J, Hudson J, Pope H. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law 2001;29(2):138-47
  8. Slovenko R. Malpractice in psychotherapy: an overview. Psychiatr Clin North Am 1999;22(1):1-15
  9. Gutheil TG. Risk management at the margins: less familiar topics in psychiatric malpractice. Harv Rev Psychiatry 1994;2(4):214-21
  10. Bleich A, Baruch Y, Hirschmann S, LubinG, MelamedY, Zemishlany Z, et al. Management of the Suicidal Patient in the Era of Defensive Medicine: Focus on Suicide RiskAssessment and Boundaries of Responsibility. Isr Med Assoc J 2011;13(11):653-6
  11. DeMello JP, DeshpandeSP. CareerSatisfaction Psychiatrists. Psychiatr Serv 2011;62(9):1013-8
  12. Franchitto N, Mathur A, Franchitto L, Gavarri L, Telmon N, Rougé D. Emergencysuicidecare in France: thepsychiatrist’sliability as seen in caselaw. Int J LawPsychiatry 2007;30(6):472-9
  13. Lin CH, Chen MC, Wang SY, Lin CY. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics. J Formos Med Assoc 2004;103(6):437-41
  14. Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int 2011;108(41):687-93
  15. Zimmerman M, Galione JN. Screening for bipolar disorder with the Mood Disorders Questionnaire: a review. Harv Rev Psychiatry 2011;9(5):219-28
  16. Hu C, Xiang Y-T, Wang G, Ungvari GS, Dickerson FB, Kilbourne AM, et al. Screening for bipolar disorder with the Mood Disorders Questionnaire in patients diagnosed as major depressive disorder — The experience in China. J Affect Disord 2012;141 (1):40-6
  17. Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU. ECNP consensus meeting